State Street’s GH Research GHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$155K Buy
11,049
+228
+2% +$3.5K ﹤0.01% 3946
2025
Q4
$137K Sell
10,821
-171
-2% -$2.33K ﹤0.01% 3984
2025
Q3
$157K Buy
+10,992
New +$154K ﹤0.01% 3967
2024
Q1
Sell
-10,704
Closed -$62.1K 4380
2023
Q4
$62.1K Hold
10,704
﹤0.01% 4157
2023
Q3
$108K Hold
10,704
﹤0.01% 4100
2023
Q2
$127K Sell
10,704
-192
-2% -$1.97K ﹤0.01% 4152
2023
Q1
$87.1K Sell
10,896
-48
-0.4% -$441 ﹤0.01% 4360
2022
Q4
$106K Buy
10,944
+48
+0.4% +$519 ﹤0.01% 4355
2022
Q3
$127K Buy
+10,896
New +$137K ﹤0.01% 4358

Other funds holding GHRS

State Street's GHRS Position: Q1 2026 in Review

State Street increased its GH Research (GHRS) stake by 2.1% in Q1 2026, buying an estimated $3.5K and bringing the position to 11,049 shares worth $155K. The position accounts for ﹤0.01% of the portfolio, ranked #3946.

State Street first reported a position in GHRS in Q3 2022 and has held it in 9 quarters since. The position peaked at $157K in Q3 2025. 54 funds tracked by Wall St. Rank hold GHRS as of Q1 2026.

  • State Street held 11,049 shares of GH Research worth $155K as of Q1 2026.
  • State Street bought 228 GH Research shares in Q1 2026, an estimated $3.5K.
  • GH Research made up ﹤0.01% of State Street's portfolio in Q1 2026, its #3946 holding.
  • State Street first reported a position in GH Research in Q3 2022 and has held it in 9 quarters since.
  • State Street's GH Research position peaked at $157K in Q3 2025.
  • 54 funds tracked by Wall St. Rank held GH Research as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.